|
|
| Accelerating genomic medicine | Traditional cell therapy manufacturing is hitting a logistical plateau that restricts patient access worldwide. Discover how the concept of the body as a bioreactor could shift the paradigm from external engineering to internal healing. Learn more |
|
|
|
|
By Anna Rose Welch, Advancing RNA | I was excited to be given the opportunity to sit down with Jodi Barrientos, CEO, Ribbon Bio, to learn more about the current state of the synthetic DNA space. In the following Q&A, Barrientos and I discuss some of the synthetic DNA industry’s biggest goals and the challenges that stand in the way of bringing synthetic plasmids more commonly into the mRNA development paradigm. | |
|
|
|
|
|
|
|
|
| Reducing Risk In mRNA Therapeutic Development | Article | Roche CustomBiotech | Advancements in purification, delivery mechanisms, and stability during storage and transport are driving the future of mRNA-based therapies by reducing systemic manufacturing risks. |
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
